| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.059 | 0.3 |